4 results  1 of 1 

1 Epigenetic modification of α-N-acetylgalactosaminidase enhances cisplatin resistance in ovarian cancer
Ye-Na Ha, Hye Youn Sung, San-Duk Yang, Yun Ju Chae, Woong Ju, Jung-Hyuck Ahn
Korean J Physiol Pharmacol.2018;22(1):43-51.   Published online 2017 December 22     DOI: http://dx.doi.org/10.4196/kjpp.2018.22.1.43
      
2 2,3,7,8-Tetrachlorodibenzo-P-Dioxin Induced Cell-Specific Drug Transporters With Acquired Cisplatin Resistance in Cisplatin Sensitive Cancer Cells
Tuvshinjargal Gotovdorj, Eunil Lee, Yongchul Lim, Eun Jeong Cha, Daeho Kwon, Eunyoung Hong, YunJeong Kim, Min-Yeong Oh
J Korean Med Sci.2014;29(9):1188-1198.   Published online 2014 September 2     DOI: http://dx.doi.org/10.3346/jkms.2014.29.9.1188
      
3 Reversal of Cisplatin Resistance by Epigallocatechin Gallate Is Mediated by Downregulation of Axl and Tyro 3 Expression in Human Lung Cancer Cells
Kyung-Chan Kim, ChuHee Lee
Korean J Physiol Pharmacol.2014;18(1):61-66.   Published online 2014 February 13     DOI: http://dx.doi.org/10.4196/kjpp.2014.18.1.61
      
4 The relationship between cisplatin resistance and histone deacetylase isoform overexpression in epithelial ovarian cancer cell lines
Min-Gyun Kim, Jhang Ho Pak, Won Ho Choi, Jeong-Yeol Park, Joo-Hyun Nam, Jong-Hyeok Kim
J Gynecol Oncol.2012;23(3):182-189.   Published online 2012 July 2     DOI: http://dx.doi.org/10.3802/jgo.2012.23.3.182
      

 1 of 1